Intuitive Surgical (NASDAQ:ISRG) Now Covered by Analysts at CICC Research

Investment analysts at CICC Research began coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a report issued on Monday. The firm set a “neutral” rating and a $550.00 price target on the medical equipment provider’s stock. CICC Research’s price objective would suggest a potential downside of 4.20% from the stock’s current price.

A number of other research firms also recently commented on ISRG. Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $574.14 on Monday. The firm’s 50 day moving average price is $548.00 and its two-hundred day moving average price is $506.12. The stock has a market cap of $204.50 billion, a PE ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Activity

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 28,749 shares of company stock valued at $15,303,875. 0.90% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Bennett Selby Investments LP grew its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares during the period. FSM Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after buying an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC lifted its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after acquiring an additional 19 shares during the period. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.